Live Analyst Rating Changes 1526 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Christine Trinh
MACQ
Christine Trinh
Macquarie
Wall Street Analyst
Not yet ranked — too few measurable calls.
—
Success Rate
—
Average Return
— vs benchmark

Rating Distribution

5 Buy 6 Hold 0 Sell
Christine's Stock Coverage 5 ratings · 2026-06-21
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return
AU:CSL
CSL
 May 11, 2026 HOLD Strong Buy
+58.3% avg upside
15 analysts
$111.00
4.60% Downside
 ·
AU:RHC
Ramsay Health Care
 Aug 29, 2025 HOLD Sell
+1.4% avg upside
14 analysts
$37.10
6.09% Downside
 ·
AU:ANN
Ansell
 Apr 08, 2025 HOLD Buy
+11.9% avg upside
9 analysts
$31.05
3.61% Upside
 ·
AU:PME
Pro Medicus Limited
 Mar 27, 2025 HOLD Strong Buy
+50.6% avg upside
7 analysts
$257.40
48.97% Upside
 ·
AU:HLS
Healius Limited
 Nov 18, 2024 HOLD Sell
+107.3% avg upside
10 analysts
$1.35
229.31% Upside
 ·
Christine Trinh — Frequently Asked Questions
How accurate are Christine Trinh's stock ratings?
Based on the calls 13Foresight could measure, about —% of Christine's ratings were profitable over a one-year hold, with an average return of —% per rating. We score every analyst the same way, from historical prices.
How is Christine ranked on 13Foresight?
Christine Trinh is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Christine cover?
Christine most recently has ratings on AU:CSL, AU:RHC, AU:ANN, AU:PME, AU:HLS. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.